IRIS PubliCatt

Autore, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.202
EU - Europa 1.759
AS - Asia 923
AF - Africa 29
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 4.932
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.185
SE - Svezia 458
IT - Italia 402
CN - Cina 401
SG - Singapore 312
DE - Germania 185
IE - Irlanda 148
FR - Francia 118
ID - Indonesia 103
UA - Ucraina 97
GB - Regno Unito 88
RU - Federazione Russa 72
FI - Finlandia 57
PL - Polonia 54
IN - India 33
CI - Costa d'Avorio 25
TR - Turchia 24
BE - Belgio 14
CA - Canada 14
CZ - Repubblica Ceca 14
HK - Hong Kong 14
JP - Giappone 12
NL - Olanda 10
ES - Italia 8
IR - Iran 8
BR - Brasile 6
AT - Austria 5
HU - Ungheria 5
GR - Grecia 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CO - Colombia 3
IL - Israele 3
KR - Corea 3
MX - Messico 3
CL - Cile 2
EG - Egitto 2
MD - Moldavia 2
NO - Norvegia 2
PH - Filippine 2
PK - Pakistan 2
VN - Vietnam 2
AR - Argentina 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MT - Malta 1
PT - Portogallo 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.932
Salva come PNG Salva come JPEG
Città #
Chandler 512
Singapore 240
Ashburn 175
Dublin 145
Jakarta 102
Beijing 87
Wilmington 83
Jacksonville 80
Dearborn 76
Ann Arbor 75
San Mateo 75
Florence 74
Nanjing 73
Rome 70
Cattolica 69
Lancaster 66
Warsaw 54
Boston 53
Princeton 52
Milan 51
Fairfield 46
Woodbridge 46
New York 42
Moscow 40
Marseille 39
Nanchang 37
Seattle 33
Houston 31
Los Angeles 29
Bremen 28
Munich 26
Abidjan 25
Helsinki 25
Lawrence 25
Redwood City 25
Kunming 21
Cambridge 20
Izmir 18
Auburn Hills 17
Redmond 17
Boardman 16
Pune 16
Shenyang 15
Brussels 14
Washington 14
Norwalk 13
Hefei 12
Hangzhou 11
Hong Kong 11
Mountain View 11
Tianjin 11
Brno 9
Hebei 9
Kyoto 9
Chicago 8
Jiaxing 8
Paris 8
Saint Petersburg 8
Shanghai 8
Zhengzhou 8
Alzate Brianza 7
Lappeenranta 7
London 7
Toronto 7
Frankfurt am Main 6
Guangzhou 6
Napoli 6
Budapest 5
North Hollywood 5
Pavia 5
Phoenix 5
Amsterdam 4
Brdo 4
Changsha 4
Engelhard 4
Falkenstein 4
Fuzhou 4
Jinan 4
Lanzhou 4
San Francisco 4
Santa Clara 4
Stockholm 4
Turin 4
Augusta 3
Bangalore 3
Bogotá 3
Central 3
Changchun 3
Clifton 3
Garden City 3
Jiangyin 3
Kish 3
Leawood 3
Monmouth Junction 3
Naples 3
Ottawa 3
San Marzano sul Sarno 3
Seregno 3
Seville 3
São Paulo 3
Totale 3.186
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 286
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 138
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 107
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 105
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 104
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 95
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 89
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 88
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 83
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 81
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 78
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 73
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 72
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 69
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 69
Unrelated cord blood transplantation and post-transplant cyclophosphamide 67
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 66
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 66
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 66
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 65
Unrelated cord blood transplantation and post-transplant cyclophosphamide 64
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 64
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 63
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 62
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 62
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 61
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 60
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 59
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 59
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 57
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 57
the concomitance of lymphoma and breast carcinoma in the bone 57
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 56
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 56
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 55
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 54
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 54
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 53
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 52
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 50
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 50
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 49
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 49
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 48
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 47
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 46
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 45
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 45
The concomitance of lymphoma and breast carcinoma in the bone 45
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 45
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 44
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 43
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 43
Second haploidentical stem cell transplantation for primary graft failure 43
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 42
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 41
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 41
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience 41
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 41
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 40
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 40
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 40
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 39
New developments in the management of chronic lymphocytic leukemia: Role of ofatumumab 38
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 38
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 38
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 35
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 35
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 35
Extending long term follow up of patient with acute myeloid leukemia after autologous stem cell transplantation: Disclosing late mortality and causes of death 35
'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy 34
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 32
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 32
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 32
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 32
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 30
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review 30
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 30
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 29
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. 29
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 28
Richter transformation in Chronic Lymphocytic Leukemia 27
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia 25
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 23
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 23
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 22
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 21
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 20
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 19
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience 18
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 17
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 17
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis 17
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 16
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 14
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 12
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation 12
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 10
Totale 5.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 0 0 0 0 81 61 27 36 42 63 35
2020/2021317 20 30 11 20 66 29 15 5 33 13 62 13
2021/2022597 51 15 26 24 51 5 7 89 32 33 136 128
2022/20231.466 203 190 107 205 103 196 81 94 168 34 64 21
2023/2024903 39 225 65 77 39 135 66 22 16 35 82 102
2024/2025521 52 61 136 71 150 51 0 0 0 0 0 0
Totale 5.095